Seven Bridges Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 294
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 4

Seven Bridges General Information

Description

Developer of a biomedical data analysis platform designed to accelerate scientific discovery. The company's platform delivers end-to-end bioinformatic data analytics including access to datasets, analytic workflows and algorithms, cloud-computing infrastructure and scientific support that speeds the path from raw experimental data to new treatments and diagnostics, enabling companies to accelerate scientific discovery with secure and collaborative genomic and healthcare data analytics.

Contact Information

Website
www.sevenbridges.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • Schrafft's City Center, 529 Main Street
  • Suite 6610, Charlestown
  • Boston, MA 02129
  • United States
+1 (617) 000-0000

Seven Bridges Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Seven Bridges Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) 27-Apr-2021 $15M 00000 00000 Completed Generating Revenue
8. Debt - PPP 01-May-2020 00000 0000 Completed Generating Revenue
7. Later Stage VC (Series B) 01-Apr-2018 0000 0000 0000 Completed Generating Revenue
6. Secondary Transaction - Private 0000 Completed Generating Revenue
5. Grant 07-Nov-2017 0000 Completed Generating Revenue
4. Later Stage VC (Series A) 16-Feb-2016 0000 0000 00000 Completed Generating Revenue
3. Grant 11-Mar-2015 00.000 000 Completed Generating Revenue
2. Seed Round 01-Jan-2014 $3M $3M 0000 Completed Startup
1. Debt - General Completed Startup
To view Seven Bridges’s complete valuation and funding history, request access »

Seven Bridges Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 000,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A1 497,354 $0.000010 $129.8 $129.8 1x $3.22 7.26%
Series A 6,690 $0.000010 $100 $100 1x $100 0%
To view Seven Bridges’s complete cap table history, request access »

Seven Bridges Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biomedical data analysis platform designed to accelerate scientific discovery. The company's platform del
Other Healthcare Technology Systems
Boston, MA
294 As of 2021
00000
0000 0000-00-00
00000000000 00000

0000000

um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qu
0000000000000 00000000
Boston, MA
000 As of 0000
00000
0000 0000-00-00
000000&0 00000

00000000

e et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
000000000 00000 (0000000000)
Mountain View, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Seven Bridges Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genuity Science Formerly VC-backed Boston, MA 000 00000 000000&0 00000
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
00000 Formerly PE-Backed Durham, NC 00000 00000 000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Seven Bridges Patents

  • 154

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 29

    Granted

  • 10

    Pending

  • 000

    Expiring in next 12 mo

Seven Bridges Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190267110-A1 System and method for sequence identification in reassembly variant calling Pending 14-Feb-2018 000000000
US-20190214110-A1 Detection of insufficient homology regions in a reference sequence Pending 07-Dec-2017 000000000
US-10678613-B2 System and method for dynamic control of workflow execution Active 31-Oct-2017 000000000 0
US-20190129769-A1 System and method for dynamic control of workflow execution Granted 31-Oct-2017 000000000
US-20200326999-A1 System and method for dynamic control of workflow execution Pending 31-Oct-2017 G06F9/543
To view Seven Bridges’s complete patent history, request access »

Seven Bridges Executive Team (29)

Name Title Board Seat Contact Info
William Moss Chief Executive Officer & Board Member
Robert Shay Chief Financial Officer
Mike Bigda Chief Operating Officer
David Ramos Chief Technology Officer
Brian Castagna Chief Information Security Officer
You’re viewing 5 of 29 executive team members. Get the full list »

Seven Bridges Board Members (6)

Name Representing Role Since
Evren Ozturk Seven Bridges Board Member 000 0000
Heng Li Seven Bridges Scientific Advisory Board Member 000 0000
James Knight Seven Bridges Scientific Advisory Board Member 000 0000
William Moss Seven Bridges Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Seven Bridges Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seven Bridges Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Kryssen Capital Venture Capital Minority 000 0000 000000 0
Genomics England Other 000 0000 000000 0
U.K. Department of Health & Social Care Government 000 0000 000000 0
To view Seven Bridges’s complete investors history, request access »

Seven Bridges Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 04-Apr-2017 000000000 Biotechnology 000000 00
To view Seven Bridges’s complete investments history, request access »

Ready to get started?

Request a free trial

Seven Bridges Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 04-Apr-2017 000000000 Completed
  • 00000 0000000
To view Seven Bridges’s complete exits history, request access »